Healthcare is a data-driven industry, but it’s held together by incompatible, siloed data systems. Providers and payers need the ability to exchange data and update directories in real time; otherwise, they cannot ensure patients will access the high-quality care they deserve. The post Inaccurate Provider Data Hinders Value-based Care, But it Doesn’t Have To appeared…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
As Congress considers changes to the Medicaid program as part of the budget debate, relatively few (17%) in the public say they want to see a reduction in Medicaid spending, with larger shares saying they want spending to stay about the same (40%) or increase (42%), a new KFF Health Tracking Poll finds. Support for…More
Kamala Harris and Donald Trump have largely different healthcare policies. However, there are some areas where they have similarities, like healthcare costs. The post On Healthcare, Trump and Harris Actually Have Some Similarities appeared first on MedCity News.
This volume examines the impact of recent executive actions on federal health communication, along with concerns and stigmas surrounding ADHD diagnoses and treatments, including skepticism about pharmaceutical influence on medication promotion. It also explores distrust in food regulations following the FDA’s ban on Red Dye No. 3.
As Congress considers ways to help pay for extending tax cuts, some lawmakers have suggested that hundreds of billions of dollars in federal savings could be achieved by addressing fraud, waste and abuse in the Medicaid program. They often cite data about improper payments in Medicaid, which accounted for 5.1 percent of total Medicaid outlays…More
Penn researchers have received funding from Advanced Research Projects Agency for Health (ARPA-H) to focus on breast cancer, heart attacks and sepsis
Higher doses of a Viking Therapeutics pill that targets two receptors led to greater weight loss without worsening safety or tolerability, according to Phase 1 results presented during the ObesityWeek conference. Meanwhile, an injectable version of this Viking drug is on track to Phase 3 testing. The post Viking Therapeutics’ Early Clinical Data Continue to…
With technology advancements specifically in the field of AI, there is a clear line of sight in making it mainstream. Here are some of the ways AI is helping to accelerate the adoption of PM. The post Precision Medicine: Becoming More Real With AI? appeared first on MedCity News.
The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartis’s labs. The antibody offers the potential to prevent blood clots without the bleeding risks associated with currently available anticoagulants. The post Novartis’s $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots appeared first on MedCity News.